63
Views
20
CrossRef citations to date
0
Altmetric
Review

Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy

&
Pages 593-601 | Published online: 14 Jul 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Herbert B Tanowitz, Fabiana S Machado, David C Spray, Joel M Friedman, Oren S Weiss, Jose N Lora, Jyothi Nagajyothi, Diego N Moraes, Nisha Jain Garg, Maria Carmo P Nunes & Antonio Luiz P Ribeiro. (2015) Developments in the management of Chagas cardiomyopathy. Expert Review of Cardiovascular Therapy 13:12, pages 1393-1409.
Read now
Werner Apt. (2010) Current and developing therapeutic agents in the treatment of Chagas disease. Drug Design, Development and Therapy 4, pages 243-253.
Read now

Articles from other publishers (18)

Emmanuel Androulakis, Debbie Falconer, Alexandros Briasoulis, Catrin Sohrabi, Wei-Yao Lim, Gerasimos Siasos, Nikhil Ahluwalia, Adam Graham & Nikolaos Papageorgiou. (2022) Long-term Outcomes of Catheter Ablation for Ventricular Arrhythmias in Post-Myocarditis Patients: Insights from a Meta-Analysis of Current Data. SN Comprehensive Clinical Medicine 4:1.
Crossref
Minerva Arce-Fonseca, Ana C. Carbajal-Hernández, Mónica Lozano-Camacho, Silvia del C. Carrillo-Sánchez, Francisco-Javier Roldán, Alberto Aranda-Fraustro, José Luis Rosales-Encina & Olivia Rodríguez-Morales. (2020) DNA Vaccine Treatment in Dogs Experimentally Infected with Trypanosoma cruzi . Journal of Immunology Research 2020, pages 1-18.
Crossref
Olivia Rodríguez-Morales, Francisco-Javier Roldán, Jesús Vargas-Barrón, Enrique Parra-Benítez, María de Lourdes Medina-García, Emilia Vergara-Bello & Minerva Arce-Fonseca. (2020) Echocardiographic Findings in Canine Model of Chagas Disease Immunized with DNA Trypanosoma cruzi Genes. Animals 10:4, pages 648.
Crossref
Yuliya Krokhaleva & Marmar Vaseghi. (2017) How to Evaluate for and Manage Inflammatory and Infiltrative Cardiomyopathies that Require Ventricular Tachycardia Ablation. Current Cardiovascular Risk Reports 11:12.
Crossref
Marco Paulo Tomaz Barbosa, Andre Assis Lopes do Carmo, Manoel Otávio da Costa Rocha & Antonio Luiz Pinho Ribeiro. (2015) Ventricular arrhythmias in Chagas disease. Revista da Sociedade Brasileira de Medicina Tropical 48:1, pages 4-10.
Crossref
José Gerardo Martínez-Tovar, Eduardo A. Rebollar-Téllez & Ildefonso Fernández Salas. (2014) SEROPREVALENCE OF T. cruzi INFECTION IN BLOOD DONORS AND CHAGAS CARDIOMYOPATHY IN PATIENTS FROM THE COAL MINING REGION OF COAHUILA, MEXICO. Revista do Instituto de Medicina Tropical de São Paulo 56:2, pages 169-174.
Crossref
Adrian Baranchuk, Francisco Femenia, Juan Cruz López-Diez, Claudio Muratore, Mariana Valentino, Enrique Retyk, Nestor Galizio, Darío Di Toro, Karina Alonso, Wilma M. Hopman & Rodrigo Miranda. (2014) Fragmented Surface ECG Was a Poor Predictor of Appropriate Therapies in Patients with Chagas’ Cardiomyopathy and ICD Implantation (Fragmented ECG in CHAgas’ Cardiomyopathy Study). Annals of Noninvasive Electrocardiology 19:1, pages 43-49.
Crossref
Bria M. Coates, David P. Sullivan, Ming Y. Makanji, Nga Y. Du, Cheryl L. Olson, William A. Muller, David M. Engman & Conrad L. Epting. (2013) Endothelial Transmigration by Trypanosoma cruzi. PLoS ONE 8:12, pages e81187.
Crossref
A.B. Saunders, S.G. Gordon, M.H. Rector, A. DeMaster, N. Jackson, F.J. Clubb, G.T. Fosgate & M.W. Miller. (2013) Bradyarrhythmias and Pacemaker Therapy in Dogs with Chagas Disease. Journal of Veterinary Internal Medicine 27:4, pages 890-894.
Crossref
Annekathrin Haberland, Silvia Gilka Munoz Saravia, Gerd Wallukat, Reinhard Ziebig & Ingolf Schimke. (2013) Chronic Chagas disease: from basics to laboratory medicine. Clinical Chemistry and Laboratory Medicine (CCLM) 51:2, pages 271-294.
Crossref
MAURICIO ARCE, JORGE VAN GRIEKEN, FRANCISCO FEMENÍA, MARTÍN ARRIETA, WILLIAM F. MCINTYRE & ADRIAN BARANCHUK. (2012) Permanent Pacing in Patients with Chagas' Disease. Pacing and Clinical Electrophysiology 35:12, pages 1494-1497.
Crossref
T C Araújo-Jorge, M C Waghabi, S Bailly & J-J Feige. (2012) The TGF-β Pathway as an Emerging Target for Chagas Disease Therapy. Clinical Pharmacology & Therapeutics 92:5, pages 613-621.
Crossref
Antonio L. Ribeiro, Maria P. Nunes, Mauro M. Teixeira & Manoel O. C. Rocha. (2012) Diagnosis and management of Chagas disease and cardiomyopathy. Nature Reviews Cardiology 9:10, pages 576-589.
Crossref
Gustavo Benaim & Alberto E. Paniz Mondolfi. (2012) The emerging role of amiodarone and dronedarone in Chagas disease. Nature Reviews Cardiology 9:10, pages 605-609.
Crossref
Adrian Baranchuk, Rodrigo Miranda & Francisco Femenía. (2012) Chagas’ cardiomyopathy and Fragmented QRS. Re: QRS fragmentation as a marker of arrhythmias in coronary artery disease, in cardiomyopathies and ion channel diseases. International Journal of Cardiology 160:2, pages 151-152.
Crossref
Antonio Dello RussoMichela CasellaMaurizio PieroniGemma PelargonioStefano BartolettiPasquale SantangeliMartina ZucchettiEster InnocentiLuigi Di BiaseCorrado CarbucicchioFulvio BellocciCesare FiorentiniAndrea NataleClaudio Tondo. (2012) Drug-Refractory Ventricular Tachycardias After Myocarditis. Circulation: Arrhythmia and Electrophysiology 5:3, pages 492-498.
Crossref
FRANCISCO FEMENÍA, MAURICIO ARCE & ADRIAN BARANCHUK. (2012) Radiofrequency Ablation of a Left Accessory Pathway Unmasks Classic Chagas’ disease ECG Pattern. Pacing and Clinical Electrophysiology 35:2, pages e38-e39.
Crossref
DARÍO DI TORO, CLAUDIO MURATORE, LUIS AGUINAGA, LUIZ BATISTA, ANTONIO MALAN, OSWALDO GRECO, CHAMIA BENCHETRIT, MAURICIO DUQUE, ADRIAN BARANCHUK & JENNIFER MALONEY. (2011) Predictors of All-Cause 1-Year Mortality in Implantable Cardioverter Defibrillator Patients with Chronic Chagas’ Cardiomyopathy. Pacing and Clinical Electrophysiology 34:9, pages 1063-1069.
Crossref